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Malnutrition in patients with cancer is common and an adverse prognostic indicator. A questionnaire answered by 357 (72%) UK
specialist oncological trainees suggests that they lack the ability to identify factors that place patients at risk from malnutrition. Major
barriers to effective nutritional practice included lack of guidelines, knowledge and time.
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As long ago as 1932, malnutrition was identified as a prognostic
indicator of the outcome in cancer patients (Warren, 1932). Up to
80% of patients with cancer are malnourished at presentation
(Dewys et al, 1980; O’Gorman et al, 1998), and in up to 20%,
malnutrition is a significant contributing factor to their death
(Ottery, 1996). Studies show poorer response to treatment, a
reduced quality of life and increased risk of death in those patients
who have lost weight (Oveson et al, 1993; Andreyev et al, 1998;
Ross et al, 2004).
Best practice, as stated by NICE Guidelines requires that patients
should undergo nutritional assessment so that those shown to be at
risk can be considered for treatment (National Institute for Clinical
Excellence, 2006). The publication Nutrition and patients: a
doctor’s responsibility (Kopelman and Lennard-Jones, 2002) set out
to raise awareness of the fundamental importance of nutritional
care in everyday clinical practice. Yet, there is overwhelming
evidence to suggest that few doctors deal with malnutrition
adequately (McWhirter and Pennington, 1994; Edington et al,
2000; Kelly et al, 2000; Beck et al, 2002). An understanding of
health professionals’ attitudes to nutrition, particularly those of
oncologists who look after patients with the highest prevalence of
malnutrition, is important if it is to be recognised efficiently and
steps taken to address it.
The aims of the study were three-fold: to develop an under-
standing of the extent to that oncologists are able to identify
malnutrition, to elucidate the importance which oncologists place
on nutrition as a variable in the clinical care and outcome of their
patient and to identify the barriers that might exist in the decision
to advocate nutritional support.
MATERIALS AND METHODS
A case-scenario-based questionnaire was developed and piloted to
address three issues: (1) the identification of malnutrition, (2) the
importance of nutritional status and support and (3) the barriers
preventing nutritional intervention. Two case scenarios in patients
with gastrointestinal cancer were used, the first related to
identification of malnutrition and the second to the role and
indication for nutritional support for a patient who had lost
weight. Additionally, their views on the importance of various
factors in treatment outcome and confidence in assessing
malnutrition were assessed.
The final version of the questionnaire was piloted in all specialist
oncological trainees at one centre. Subsequently, on the basis of
the responses recorded, it was decided to send it out to all UK
trainees, identified by their membership of the Association of
Cancer Physicians, UK or the Royal College of Radiologists, UK.
The scenarios were content validated by a group of defined UK
experts on malnutrition, who set the expert standard.
Results were analysed using SPSS v13. Frequencies were
described and w
2 tests were used to assess whether there
were associations between nutritional practice, knowledge and
attitudes and clinical speciality, nutritional education or years of
clinical and oncology experience. Significance was established at
Po0.05.
RESULTS
Between April and June 2003, 61 pilot questionnaires were
distributed to trainees in one institution. Subsequently, between
September 2004 and April 2005, a further 433 questionnaires were
sent out to all trainees in the UK. Of 494 questionnaires in total,
357 were returned (72% response rate). Of these, six were not
completed because the recipient was no longer working in
oncology, and 14 because they were not available at the given
address. Of the 337 completed, the maximum missing data for any
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sscenario response on completed questionnaires was less than 2%
(no7). Nineteen questionnaires were sent out to experts, of whom
16 replied (84%). The characteristics of the responders are shown
in Table 1.
Do oncologists consider nutrition important to outcome?
Almost all specialist oncological trainees thought that ‘stage’ or
‘performance status’ was very important to the outcome, but
nearly two-thirds (65%, n¼217) rated nutritional status as very
important. Age and patient attitude were rated as much less
important (Table 2a).
In the case study scenario, nearly all trainees thought that the
patient’s morbidity and quality of life would be affected by
nutritional intervention. A substantial majority also felt that
nutrition intervention would play a role in hospital stay (76%,
n¼255) and treatment toxicity (78%, n¼261), but a larger
number indicated uncertainty. Trainees were least likely to agree
that nutritional intervention would play a role in mortality with
regard to this patient (Table 2b).
Can oncologists identify malnutrition?
The majority of specialist oncological trainees (80%, n¼267)
expressed uncertainty or a lack of confidence in their ability to
identify malnutrition. Those who had undergone undergraduate
nutritional lectures were more confident (Po0.01), but no
association was found between confidence and speciality (medical
vs clinical oncologist) age, medical or oncological experience or
type of hospital was seen.
There was a discrepancy (Table 3a) between trainees who
significantly more frequently identified the case patient as
definitely malnourished in comparison to experts (Po0.05).
When asked which variables they would find useful to assess
nutritional status (Table 3b), 48% (n¼160) of trainees failed to
specify height and/or body mass index. Just over one-quarter of
trainees identified the additional variables necessary to identify
risk according to the Malnutrition Advisory Guidelines (MAG),
Malnutrition Universal Screening Tool (‘MUST’) criteria or the
Malnutrition Screening Tool (MST), compared to over three-
quarters of experts. A similar pattern was shown by trainees (29%,
n¼97), in recording half or more of the six variables required to
identify nutritional risk according to the Patient Generated
Subjective Global Assessment (PG-SGA), a specific and validated
tool for assessing cancer patients’ nutritional status. The ability of
oncologist trainees to identify relevant variables was associated
with undergraduate nutrition lectures (Po0.05) but not with
medical or oncological experience.
When asked to identify the level of weight loss in a 1-month
period, which indicated that nutritional intervention was necessary
(Table 3c; case scenario 2), again specialist oncological trainees
gave significantly different replies to experts (Po0.05), who
considered nutritional intervention as necessary at a lower level
of weight loss than the trainees.
Table 1 Respondent characteristics
Oncologist SpR, n (%)
Gender
Male 144 (37)
Female 210 (62)
Not indicated 3 (o1)
Age (years)
p30 62 (18)
31–34 175 (52)
35–39 77 (23)
X40 17 (5)
Not indicated 6 (2)
Specialisation
Medical Oncologist 139 (41)
Clinical Oncologist 182 (54)
Surgery 4 (1)
Palliative Care 2 (o1)
Pediatrics 3 (o1)
Hematology 1 (o1)
GP 1 (o1)
Not indicated 5 (2)
Hospital
District General 25 (7)
Teaching 143 (42)
Tertiary 163 (48)
Not indicated 6 (2)
Place of training
UK 286 (85)
Europe 24 (7)
Australia 4 (1)
South Asia 11 (3)
South Africa 4 (1)
Middle East 2 (o1)
West Indies 1 (o1)
Not indicated 4 (1)
Clinical experience (years since full medical registration)
o10 194 (58)
X10 138 (41)
Not indicated 5 (2)
Oncologic experience (years working in oncology)
o5 174 (52)
X5 158 (47)
Not indicated 5 (2)
Nutritional education
Undergraduate lectures 118 (35)
Postgraduate education 35 (10)
Interest in further nutritional training 270 (80)
Table 2 Do trainee oncologists consider nutrition important to
outcome?
(a) Importance of different factors to outcome (0 not important–5
very important) (total completed 334)
4–5 response, n (%) Median Range
Stage 321 (96) 5 3–5
Performance status 324 (97) 5 3–5
Nutritional status 217 (65) 4 1–5
Age 124 (37) 3 0–5
Patient attitude 127 (38) 3 0–5
(b) Importance of nutritional intervention to outcome
‘In a patient with 11% weight loss would nutritional intervention play
a role’ (Yes, No, Uncertain) (total completed 335)
Yes, n (%) No, n (%) Uncertain, n (%)
Mortality 188 (56) 57 (17) 90 (27)
Morbidity 305 (91) 7 (2) 23 (7)
Hospital stay 255 (76) 10 (3) 67 (20)
Quality of life 318 (95) 0 (0) 17 (5)
Toxicity from treatment 261 (78) 27 (8) 47 (14)
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patient care?
As shown in Table 4, the three principal barriers to nutritional
intervention by specialist oncological trainees were reported
to be lack of clear guidelines (n¼231, 69%), lack of knowledge
(n¼201, 60%) and lack of time (n¼188, 56%). Two hundred and
seventy (80%) oncological trainees wanted additional training in
this area.
DISCUSSION
The study suggests that oncologist trainees accept that nutritional
status and nutritional intervention are important to outcome in
patients receiving active therapy for malignancy. However, there is
an inability to identify patients at risk of malnutrition and to refer
those who may benefit from early nutritional intervention. Further
barriers include a lack of recognised guidelines as to when to
recommend nutritional intervention for weight loss.
Timely and appropriate interventions for patients with cancer
require adoption of routine nutritional screening and evaluation
(Ottery, 1995). Yet, hospital surveys suggest nutritional risk
screening and assessment as part of routine practice is generally
not performed (Duncan and Silk, 1997; Kondrup et al, 2002).
It has been shown that malnutrition is largely unrecognised
by health professionals (Edington et al, 2000). Similar findings
more recently have come from The Council of Europe
Group survey on nutritional care in European hospitals
(Beck et al, 2002). Our study suggests that these findings on
generalised hospital populations are also relevant in the oncolo-
gical setting. This is particularly important as oncological
treatment is increasingly given in the ‘outpatient’ setting
where any standard ward-based nutrition assessment tool is
not typically used. This study suggests that oncology trainees
fail to identify patients appropriately for nutritional assessment,
not because they think it is unimportant but rather because
of lack of ability, confidence and knowledge of important
criteria, which should determine effective nutritional
practice.
There are limitations inherent in the questionnaire as a method
of survey. Ideally, stringent methods of validation and reliability
testing are required. However, our questionnaire was developed
after a pilot study. This study is also limited in that it addresses the
outcome at which behaviour is directed rather than the actual
behaviour. Further research would need to ascertain actual rather
than reported nutrition practice.
The study suggests that future research also needs to be
directed at the best method of providing effective, concise
and relevant nutritional education interventions to oncologist
trainees.
In conclusion, oncologists lack the ability to identify factors
that place patients at risk from malnutrition. Although oncologists
acknowledge the importance of nutritional support, barriers
such as lack of knowledge, clear guidelines and lower priority
because of time constraints may prevent referral for, or direct
nutritional intervention. Until the ethos of optimal nutritional
management is strengthened in clinical practice, probably
through continuing effective education and training at all levels
within the medical profession, the rate of untreated malnutrition
may remain unacceptably high and continue to compromise
patient outcomes.
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Table 3 Can trainee oncologists identify patients at risk of malnutrition?
Case Scenario 1:
69-year-old female with GI tumour, third cycle chemotherapy,
weight 54kg, albumin 25gl
 1, CRP 18mgl
 1, other biochemistry
normal
Oncologist, n
(%)
Expert, n
(%)
(a) Is this patient:
Definitely malnourished 137 (41) 2 (14)
At risk of malnutrition/cannot be assessed
from the information given
197 (59) 14 (86)
(b) What further variables would be required for nutritional assessment?
Height and/or BMI 174 (52) 15 (94)
BMI and weight history (MAG tool) 97 (29) 13 (81)
Case Scenario 2:
56-year-old male with GI tumour to commence chemotherapy,
biochemistry normal, no comorbidity weight 62kg, usual weight
70kg,
(c) What weight loss over 1 month indicates need for nutritional intervention
1–4% (or kg eq) 10 (3) 1 (7)
5–9% (or kg eq) 150 (45) 12 (75)
10–14% (or kg eq) 157 (47) 3 (21)
15+% (or kg eq) 10 (3) 0 (0)
No intervention 7 (2) 0 (0)
BMI¼body mass index, CRP¼C-reactive protein, eq¼equivalent, GI¼gastro-
intestinal, MAG¼Malnutrition Advisory Guidelines.
Table 4 What barriers prevent inclusion of nutrition on oncologist
patient care?
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